ASXL1 and colorectal cancer: Gain of ASXL1, also located on 20q11.21, thought to be a tumor suppressor, is associated with a favorable prognosis; patients with ASXL1 gain had a mean survival time of 48 months, significantly longer than 41 months in patients with ASXL1 negative colorectal cancer [64].